Fisetin is a plant-based flavonoid found naturally in strawberries, apples, and other fruits that has drawn attention for its potential to clear damaged cells, protect the brain, and slow aspects of aging. Most of the evidence comes from lab and animal studies, with human trials still in early stages, but the findings so far explain why fisetin has become one of the most discussed longevity supplements.
Clearing Out “Zombie” Cells
The benefit generating the most scientific interest is fisetin’s ability to act as a senolytic, a compound that selectively destroys senescent cells. Senescent cells are sometimes called “zombie cells” because they stop dividing but refuse to die. Instead, they linger in tissues and release inflammatory signals that damage surrounding healthy cells, contributing to age-related decline in organs, joints, and the immune system. Senescent cells resist the normal self-destruct process because they ramp up internal survival pathways that protect them from being cleared away.
In a widely cited study published in The Lancet’s eBioMedicine, researchers tested 10 different flavonoids and found fisetin was the most potent senolytic of the group. When given to aged mice, even short or intermittent doses reduced markers of cellular senescence across multiple tissues. The researchers described this as a “hit-and-run” mechanism: fisetin doesn’t need to be taken continuously to have an effect. Brief exposure can trigger the cleanup process.
That said, the leap from mice to humans is significant. A Mayo Clinic researcher cautioned that many people are already taking commercial fisetin or related compounds as anti-aging agents “without knowing if they have high enough senescent cell numbers to benefit, or what dose or dosing regimen is needed to be effective yet safe.” Human trials are underway but haven’t yet confirmed the same senolytic effects seen in animals.
Brain Health and Cognitive Protection
Fisetin has shown neuroprotective effects in preclinical research, reducing oxidative stress and inflammation in brain tissue. Animal studies suggest it can help preserve memory and protect neurons from the kind of damage associated with aging and neurodegenerative diseases. These findings have been promising enough to push the compound into formal human testing.
A Phase 2 clinical trial is currently evaluating fisetin in adults aged 60 and older who have mild cognitive impairment or mild Alzheimer’s disease dementia. The trial is using a dose of 20 mg per kilogram of body weight per day and is primarily measuring safety and tolerability rather than cognitive improvement. This means researchers are still in the process of confirming that fisetin is safe at therapeutic doses in this population before testing whether it meaningfully slows cognitive decline. Results are not yet available, so any claims about fisetin treating or preventing Alzheimer’s are premature.
Skin Protection Against UV Damage
UV radiation ages skin partly by triggering the production of enzymes called MMP-1 and MMP-3, which break down collagen and the structural matrix that keeps skin firm. Lab research using human skin cells found that fisetin significantly reduced the expression of both enzymes after UVA exposure. It did this by blocking a chain reaction: UV light triggers reactive oxygen species (free radicals), which activate stress-signaling pathways in skin cells, which then ramp up collagen-degrading enzyme production. Fisetin interrupted this process at the earliest step by suppressing free radical production.
This has been demonstrated in both the deeper layer of skin (dermal fibroblasts) and the outer layer (epidermal keratinocytes), suggesting broad protective activity. However, this research was conducted in cell cultures, not in people applying fisetin topically or taking it orally. Whether dietary or supplemental fisetin reaches the skin in meaningful concentrations remains an open question.
Food Sources and How Much You Actually Get
Strawberries are by far the richest dietary source of fisetin, containing about 160 micrograms per gram of fruit. That translates to roughly 16 milligrams in 100 grams of strawberries (a little under a cup). After strawberries, the amounts drop off sharply:
- Apples: 26.9 µg/g
- Persimmons: 10.6 µg/g
- Lotus root: 5.8 µg/g
- Onions: 4.8 µg/g
- Grapes: 3.9 µg/g
- Kiwi: 2.0 µg/g
To put this in perspective, human supplementation studies typically use 20 to 100 mg per day for general health purposes, and senolytic research uses much higher intermittent doses of around 20 mg per kilogram of body weight for two to three consecutive days. You would need to eat several pounds of strawberries daily to approach even the lower supplemental range, which is why most research uses concentrated supplements rather than whole foods.
The Bioavailability Problem
One of fisetin’s biggest practical challenges is that your body absorbs very little of it. Fisetin has limited water solubility and poor bioavailability, meaning most of what you swallow passes through without reaching the bloodstream in useful amounts. This is a known limitation across many flavonoids, but it’s especially relevant for fisetin because the doses that produced results in lab studies may not translate to what actually reaches your tissues after oral consumption.
Researchers have explored liposomal formulations, where fisetin is encapsulated in tiny fat-based particles, to solve this problem. One study found that a liposomal version achieved a 47-fold increase in bioavailability compared to free fisetin. Some supplement manufacturers now sell liposomal or fat-soluble formulations based on this principle, though the specific formulations used in published research may differ from commercial products. Taking fisetin with a fat-containing meal may also improve absorption, though this hasn’t been rigorously quantified in human studies.
Safety and Side Effects
Fisetin appears to have a favorable safety profile based on available data. Preclinical studies show low acute toxicity, and reported side effects in human use are rare, generally limited to mild gastrointestinal discomfort. Animal studies at very high doses have shown some signs of liver stress, but these were observed at levels well above what’s typically used in supplementation.
An ongoing clinical trial (estimated completion in 2026) is testing 100 mg of fisetin daily for seven weeks in healthy adults to gather more formal safety and aging-related data. Until larger human trials report results, the long-term safety of regular fisetin supplementation, particularly at the high intermittent doses used in senolytic protocols, remains uncertain.
Where the Evidence Actually Stands
Fisetin sits in an unusual position: the preclinical data is genuinely compelling, especially for senolytic activity and neuroprotection, but the human evidence hasn’t caught up yet. Most of what’s known comes from cell culture experiments and mouse studies. The handful of human trials that exist are early-phase, focused on safety rather than efficacy, and haven’t published final results.
This gap matters because many supplements that look promising in animal models fail to deliver the same benefits in people. Fisetin’s poor natural bioavailability adds another layer of uncertainty. If you’re considering supplementation, the current landscape suggests a compound with real scientific interest behind it but without the clinical proof to back up the strongest claims circulating online.